Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BNT116 |
| Trade Name | |
| Synonyms | BNT-116|BNT 116 |
| Drug Descriptions |
BNT116 is composed of liposomal RNAs encoding 6 tumor-associated antigens, which may potentially inhibit tumor growth (Ann Oncol (2022) 33 (suppl_7): S1095). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C201496 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BNT116 | BNT116 | 0 | 1 |
| BNT116 + Carboplatin + Cemiplimab + Paclitaxel | BNT116 Carboplatin Cemiplimab Paclitaxel | 0 | 1 |
| BNT116 + Cemiplimab | BNT116 Cemiplimab | 0 | 2 |
| BNT116 + Docetaxel | BNT116 Docetaxel | 0 | 1 |
| BNT116 + ONC-392 | BNT116 ONC-392 | 0 | 1 |